Evidence map›Paper›PMID 32571478›Full record

ArticleeLife2020

Sequentially induced motor neurons from human fibroblasts facilitate locomotor recovery in a rodent spinal cord injury model.

Hyunah Lee, Hye Yeong Lee, Byeong Eun Lee, Daniela Gerovska, Soo Yong Park, Holm Zaehres, Marcos J Araúzo-Bravo, Jae-Ick Kim, Yoon Ha, Hans R Schöler and 1 more

Abstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. bioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Biomaterials and cell-based therapy post spinal cord injury.Journal of translational medicine · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hyunah LeeHans Schöler Stem Cell Research Center (HSSCRC), Ulsan National Institute of Science and Technology (UNIST), Ulsan, Republic of Korea.ORCID 0000-0002-5560-5969
Hye Yeong LeeDepartment of Neurosurgery, Spine and Spinal Cord Institute, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Byeong Eun LeeSchool of Life Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan, Republic of Korea.
Daniela GerovskaComputational Biology and Systems Biomedicine Group, Computational Biomedicine Data Analysis Platform, Biodonostia Health Research Institute, San Sebastián, Spain.ORCID 0000-0003-0671-4277
Soo Yong ParkHans Schöler Stem Cell Research Center (HSSCRC), Ulsan National Institute of Science and Technology (UNIST), Ulsan, Republic of Korea.
Holm ZaehresDepartment of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Marcos J Araúzo-BravoComputational Biology and Systems Biomedicine Group, Computational Biomedicine Data Analysis Platform, Biodonostia Health Research Institute, San Sebastián, Spain.ORCID 0000-0002-3264-464X
Jae-Ick KimSchool of Life Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan, Republic of Korea.
Yoon HaDepartment of Neurosurgery, Spine and Spinal Cord Institute, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Hans R SchölerDepartment of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
Jeong Beom KimHans Schöler Stem Cell Research Center (HSSCRC), Ulsan National Institute of Science and Technology (UNIST), Ulsan, Republic of Korea.ORCID 0000-0001-6230-8826

Funding

Austrian Science Fund FWF I 3734European Union Eracosysmed/H2020 643271Instituto de Salud Carlos III AC17/00012Korea Ministry of SMEs and Startups S2566811Ministry of Economy and Competitiveness of Spain MINECO BFU2016-77987-PNational Research Foundation of Korea 2017R1C1B3005476
6 · The paper itself

Abstract

Generation of autologous human motor neurons holds great promise for cell replacement therapy to treat spinal cord injury (SCI). Direct conversion allows generation of target cells from somatic cells, however, current protocols are not practicable for therapeutic purposes since converted cells are post-mitotic that are not scalable. Therefore, therapeutic effects of directly converted neurons have not been elucidated yet. Here, we show that human fibroblasts can be converted into induced motor neurons (iMNs) by sequentially inducing

Indexed as

Gene Expression RegulationAnimalsCell TransplantationDisease Models, AnimalFemaleFibroblastsHumansLIM-Homeodomain ProteinsLocomotionMaleMiceMice, NudeMotor NeuronsOctamer Transcription Factor-3Recovery of FunctionSpinal Cord InjuriesLhx3 proteinLIM-Homeodomain ProteinsOctamer Transcription Factor-3POU5F1 protein, humanTranscription Factorscell replacement therapydirect conversionhumaninduced motor neuronsregenerative medicineself-renewalspinal cord injurystem cells

Identifiers

PMID32571478
PMCPMC7311175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.